Back

Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction

27 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Michaela Meyer

Bayer AG, Wuppertal (Germany)

42 More presentations in this session

Presentation thumbnail
Professor A. Kurlianskaya (Minsk, BY)
Abstract
Presentation thumbnail
Professor A. Berezin (Salzburg, AT)
Abstract Slides
Presentation thumbnail
Doctor O. Shatova (Minsk, BY)
Abstract
Presentation thumbnail
Ms C. Farrell (Letterkenny, IE)
Abstract Slides
Presentation thumbnail
Doctor A. Giraldez Valpuesta (Jerez de la Frontera, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2019

27 May 2019 08:30 CET
You may be interested in
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Transforming heart failure care: unlocking new pathways

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources